📖[PDF] Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions (Edition 1) by Hyewon Ahn | Perlego
Get access to over 700,000 titles
Start your free trial today and explore our endless library.
Join perlego now to get access to over 700,000 books
Join perlego now to get access to over 700,000 books
Join perlego now to get access to over 700,000 books
Join perlego now to get access to over 700,000 books
Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions (Edition 1)
Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions (Edition 1)
📖 Book - PDF

Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions (Edition 1)

Hyewon Ahn
shareBook
Share book
language
English
format
PDF
unavailableOnMobile
Only available on web
📖 Book - PDF

Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions (Edition 1)

Hyewon Ahn
Book details
Table of contents
Citations

About This Book

The thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions. This thesis provides an overview on the technology and patenting practice, followed by the discussion of jurisprudence on the patentability requirements for selection inventions in major jurisdictions. In particular, the paper examines the novelty and the non-obviousness requirements. As the discussion on the anticipation and obviousness is more contentious in selection inventions, this discusses the issues in view of the two decisions. Post grant impact of selection inventions and their meanings to the system of patent are explored, and some comparative perspectives on selection inventions are discussed. In conclusion, by exploring the significance of granting patents on selection invention to the working of patent system, this paper aims to provide a useful analysis in understanding patentability requirements thereof, beyond the pharmaceutical industry sector.The author researches on improvement patents in the field of pharmaceutical industry at the Max-Planck Institute in Munich.

Read More

Information

Publisher
Nomos Verlagsgesellschaft mbH & Co. KG
Year
2011
ISBN
9783845232188
Topic
Law
Subtopic
Commercial Law

Table of contents